Investor Relations

Investor Relations

Latest News View All News

Jun 12, 2019 • 4:05 PM EDT

Cerecor Appoints Keith Schmidt to its Board of Directors

Jun 11, 2019 • 1:00 PM EDT

Cerecor Set to Join Russell 3000® Index

May 9, 2019 • 4:05 PM EDT

Cerecor Reports First Quarter 2019 Results

Stock Information View Detailed Stock Information

Nasdaq: CERC Cerecor, Inc.
Day Range
52 Week Range

Company Overview

Cerecor is an integrated biopharmaceutical company developing innovative therapies at the cutting edge of science. Our pipeline, filled with forward-thinking ideas, propels us forward. We are driven to change the lives of patients with rare orphan diseases in Pediatrics and Neurology.